Skip to main content

Expert commentary: Results from the pediatric medication arm of the RISE trial

Dana Dabelea discusses the RISE investigators’ findings about the physiology of type 2 diabetes in children and the effects of medication on its progression (7:38).

More on this topic

CME-accredited webcast

Learn more about real-world evidence of new GLP-1RAs with Melanie Davies, Stewart Harris & Takashi Kadowaki

Image Credits